Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Pediatric Nephrology (Berlin, Germany)|September 17, 2013
Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndromeCengiz Candan, Nur Canpolat, Selman Gökalp, et al.
Pediatric Nephrology (Berlin, Germany)|November 5, 2008
Progression of coronary calcification in pediatric chronic kidney disease stage 5Mahmut Civilibal, Salim Caliskan, Sebuh Kurugoglu, et al.
The Turkish Journal of Pediatrics|February 28, 2020
Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementationMustafa Atmaca, Bora Gülhan, Emine Atayar, et al.
Pediatric Nephrology (Berlin, Germany)|March 7, 2007
Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patientsMahmut Civilibal, Salim Caliskan, Huseyin Oflaz, et al.
International Urology and Nephrology|August 12, 2008
Left ventricular systolic and diastolic function and carotid intima-media thickness in pediatric dialysis patientsMahmut Civilibal, Huseyin Oflaz, Salim Caliskan, et al.
Pediatric Nephrology (Berlin, Germany)|October 11, 2011
Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease?Nur Canpolat, Salim Caliskan, Lale Sever, et al.
European Journal of Pediatric Surgery Reports|December 7, 2022
Bilateral Native Kidney Papillary Renal Cell Carcinomas in a 11-Year-Old Renal Transplant PatientÇiğdem Ulukaya Durakbaşa, Deniz Ugurlu, Sabriye Gulcin Bozbeyoglu, et al.
Pediatric Nephrology (Berlin, Germany)|July 6, 2006
Coronary artery calcifications in children with end-stage renal diseaseMahmut Civilibal, Salim Caliskan, Ibrahim Adaletli, et al.
Pediatric Nephrology (Berlin, Germany)|March 25, 2017
Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatmentMustafa Atmaca, Bora Gulhan, Emine Korkmaz, et al.
Pediatric Nephrology (Berlin, Germany)|August 31, 2018
Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumabAyşe Ağbaş, Nilüfer Göknar, Nurver Akıncı, et al.
Pageof 4